Bausch Health Companies Stock Net Income
| BHC Stock | CAD 7.84 0.07 0.90% |
As of the 6th of February, Bausch Health shows the Mean Deviation of 2.16, risk adjusted performance of (0.05), and Standard Deviation of 3.11. Bausch Health Companies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Bausch Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.1781 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -64.8 M | -68 M | |
| Net Loss | -64.8 M | -68 M | |
| Net Loss | -41.4 M | -43.5 M | |
| Net Loss | (0.14) | (0.15) | |
| Net Loss | (0.32) | (0.30) |
Bausch | Net Income |
Evaluating Bausch Health's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Bausch Health Companies's fundamental strength.
Latest Bausch Health's Net Income Growth Pattern
Below is the plot of the Net Income of Bausch Health Companies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bausch Health Companies financial statement analysis. It represents the amount of money remaining after all of Bausch Health Companies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bausch Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bausch Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (72 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Bausch Net Income Regression Statistics
| Arithmetic Mean | (502,251,647) | |
| Coefficient Of Variation | (276.98) | |
| Mean Deviation | 915,103,585 | |
| Median | (212,000,000) | |
| Standard Deviation | 1,391,159,277 | |
| Sample Variance | 1935324.1T | |
| Range | 6.6B | |
| R-Value | (0.06) | |
| Mean Square Error | 2056347.9T | |
| R-Squared | 0 | |
| Significance | 0.81 | |
| Slope | (17,147,581) | |
| Total Sum of Squares | 30965186.2T |
Bausch Net Income History
Bausch Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Bausch Health is extremely important. It helps to project a fair market value of Bausch Stock properly, considering its historical fundamentals such as Net Income. Since Bausch Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bausch Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bausch Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Bausch Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bausch Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bausch Health.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Bausch Health on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Bausch Health Companies or generate 0.0% return on investment in Bausch Health over 90 days. Bausch Health is related to or competes with Curaleaf Holdings, Tilray, Cronos, Cipher Pharmaceuticals, and Biosyent. Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the... More
Bausch Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bausch Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bausch Health Companies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 22.29 | |||
| Value At Risk | (4.43) | |||
| Potential Upside | 4.58 |
Bausch Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bausch Health's standard deviation. In reality, there are many statistical measures that can use Bausch Health historical prices to predict the future Bausch Health's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.39) |
Bausch Health February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.38) | |||
| Mean Deviation | 2.16 | |||
| Coefficient Of Variation | (1,204) | |||
| Standard Deviation | 3.11 | |||
| Variance | 9.7 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.39) | |||
| Maximum Drawdown | 22.29 | |||
| Value At Risk | (4.43) | |||
| Potential Upside | 4.58 | |||
| Skewness | 0.259 | |||
| Kurtosis | 3.83 |
Bausch Health Companies Backtested Returns
Bausch Health Companies secures Sharpe Ratio (or Efficiency) of -0.0541, which signifies that the company had a -0.0541 % return per unit of risk over the last 3 months. Bausch Health Companies exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bausch Health's Mean Deviation of 2.16, risk adjusted performance of (0.05), and Standard Deviation of 3.11 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bausch Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bausch Health is expected to be smaller as well. At this point, Bausch Health Companies has a negative expected return of -0.17%. Please make sure to confirm Bausch Health's accumulation distribution, and the relationship between the potential upside and day median price , to decide if Bausch Health Companies performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.62 |
Very good reverse predictability
Bausch Health Companies has very good reverse predictability. Overlapping area represents the amount of predictability between Bausch Health time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bausch Health Companies price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Bausch Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 1.23 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Bausch Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Bausch Health Companies reported net income of (72 Million). This is 121.1% lower than that of the Pharmaceuticals sector and 81.3% lower than that of the Health Care industry. The net income for all Canada stocks is 112.61% higher than that of the company.
Bausch Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bausch Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics of similar companies.Bausch Health is currently under evaluation in net income category among its peers.
Bausch Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bausch Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bausch Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Bausch Fundamentals
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.0483 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 29.8 B | ||||
| Shares Outstanding | 370.52 M | ||||
| Shares Owned By Insiders | 10.68 % | ||||
| Shares Owned By Institutions | 64.53 % | ||||
| Number Of Shares Shorted | 1.5 M | ||||
| Price To Book | 18.74 X | ||||
| Price To Sales | 0.29 X | ||||
| Revenue | 9.62 B | ||||
| Gross Profit | 7.09 B | ||||
| EBITDA | 2.82 B | ||||
| Net Income | (72 M) | ||||
| Cash And Equivalents | 1.18 B | ||||
| Cash Per Share | 2.49 X | ||||
| Total Debt | 21.62 B | ||||
| Debt To Equity | 906.20 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | (2.08) X | ||||
| Cash Flow From Operations | 1.6 B | ||||
| Short Ratio | 3.11 X | ||||
| Earnings Per Share | 1.32 X | ||||
| Price To Earnings To Growth | 0.02 X | ||||
| Target Price | 6.78 | ||||
| Number Of Employees | 20.7 K | ||||
| Beta | 0.38 | ||||
| Market Capitalization | 2.9 B | ||||
| Total Asset | 26.52 B | ||||
| Retained Earnings | (9.82 B) | ||||
| Working Capital | (978 M) | ||||
| Net Asset | 26.52 B |
About Bausch Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving against Bausch Stock
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.